A large genomic database study of over 2100 uterine tumors using next-generation sequencing confirmed the predominance of TP53 mutations, and recurrent alterations of PIK3CA, PPP2R1A, ERBB2, CCNE1, FBXW7 and MYC (28). Here, PPP2R1A is linked to tumor of uterus.